Skip to content

WINROP Algorithm Validation for Retinopathy Screening in a Cohort of Premature Infants

WINROP Algorithm Validation for Retinopathy Screening in Premature Infants: a Retrospective Cohort Analysis Over 4 Years

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03347799
Acronym
WINROP
Enrollment
570
Registered
2017-11-20
Start date
2012-07-01
Completion date
2017-09-01
Last updated
2023-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of Prematurity

Keywords

very premature infants, screening, retinopathy

Brief summary

When a child was born too early, it is more likely to develop an alteration of its visual function than in the case of term birth. Significant visual disturbances are found in 3% of children born prematurely, but visual impairment can be very severe, up to the loss of vision in case of retinopathy of prematurity (ROP) in the most immature infants. The introduction of screening surveillance systems, such as WINROP software, might reduce the need for stressful eye examination in low risk neonates. This retrospective study aimed at validating the WINROP algorithm in a cohort of premature infants, born below 32 weeks of gestation, who had systematic eye examination for ROP screening over 4 year period.

Interventions

None listed

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
24 Weeks to 40 Weeks
Healthy volunteers
No

Inclusion criteria

* All infants born below 32 weeks gestation within the study period * At least one eye examination recorded by Retcam

Exclusion criteria

* Any ophthalmic abnormality * Any genetic abnormality

Design outcomes

Primary

MeasureTime frameDescription
algorithm validationfrom birth up to 40 weeks post menstrual agerisk of retinopathy occurence

Secondary

MeasureTime frameDescription
risk factor for retinopathyfrom birth up to 40 weeks post menstrual agestandardized perinatal data collection

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026